Ore Pharmaceutical (GLGC) 10-K 2002 FY Annual report

EXHIBIT 10.99

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of Gene Logic Inc. (the “Company”) on Form 10-K for the year ending December 31, 2002, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of Mark D. Gessler, the Chief Executive Officer of the Company, and Philip L. Rohrer, Jr., the Chief Financial Officer of the Company, hereby certify, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

By:	/s/ Mark D. Gessler	By:	/s/ Philip L. Rohrer, Jr.
	Mark D. Gessler		Philip L. Rohrer, Jr.
	Chief Executive Officer		Chief Financial Officer
	March 19, 2003		March 19, 2003